Tuesday, September 20, 2016

GlaxoSmithKline Names Emma Walmsley as Chief Executive Officer Designate

GlaxoSmithKline has named Emma Walmsley as chief executive officer designate to take over from Andrew Witty when he retires next year.

from WSJ.com: US Business http://ift.tt/2d7vk03
via IFTTT

No comments:

Post a Comment